Literature DB >> 15511607

Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART.

S Landonio1, T Quirino, P Bonfanti, A Gabris, L Boccassini, C Gulisano, L Vulpio, E Ricci, M Carrabba, G M Vigevani.   

Abstract

In the last few years there are increasing evidences suggesting that osteopenia and osteoporosis are frequent among HIV positive patients. It is still not clear if the bone demineralization is a direct consequence of viral infection or of the antiretroviral drugs. Studies to date therefore give conflicting results. We performed a study to evaluate the prevalence of osteopenia and osteoporosis in HIV positive patients, either untreated or receiving antiretroviral therapy, to asses the frequency of these conditions and the role of antiretroviral drugs.

Entities:  

Mesh:

Year:  2004        PMID: 15511607     DOI: 10.1016/j.biopha.2004.08.019

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

Review 1.  Bone and vitamin D metabolism in HIV.

Authors:  Aristotle Panayiotopoulos; Nandini Bhat; Amrit Bhangoo
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

2.  Longitudinal analysis of bone density in human immunodeficiency virus-infected women.

Authors:  Sara E Dolan; Jenna R Kanter; Steven Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

3.  Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women.

Authors:  M T Yin; R Modarresi; E Shane; F Santiago; D C Ferris; D J McMahon; C A Zhang; S Cremers; J Laurence
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

4.  Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Yungtai Lo; Robert S Klein
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

Review 5.  Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.

Authors:  Erdembileg Anuurad; Alison Semrad; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2009-10       Impact factor: 1.894

6.  Factors Associated with Bone Mineral Density and Bone Resorption Markers in Postmenopausal HIV-Infected Women on Antiretroviral Therapy: A Prospective Cohort Study.

Authors:  Christa Ellis; Herculina S Kruger; Michelle Viljoen; Joel A Dave; Marlena C Kruger
Journal:  Nutrients       Date:  2021-06-18       Impact factor: 5.717

7.  Differences in Serum Levels of Magnesium, Phosphate, and Albumin for HAART-Experienced and HAART-Naïve Female Patients Attending Parirenyatwa Opportunistic Infections Clinic in Harare, Zimbabwe.

Authors:  Denise Mudzinge; Tinashe Kenny Nyazika; Tawanda Jonathan Chisango; Danai Tavonga Zhou
Journal:  ISRN AIDS       Date:  2013-09-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.